Skip to content

Effects of dexmedetomidine on periarticular infiltration analgesia in total knee arthroplasty: a prospective, double-blind, randomized controlled trial

Effects of dexmedetomidine on periarticular infiltration analgesia in total knee arthroplasty: a prospective, double-blind, randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036316
Enrollment
Unknown
Registered
2020-08-22
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis/ knee rheumatoid arthritis

Interventions

B:Drug composition of local infiltration around the joint is: Ropivacaine and dexmedetomidine

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) patients requiring unilateral initial TKA surgery due to severe knee osteoarthritis or rheumatoid arthritis; (2) aged 18 to 80 years; (3) body mass index was 20~35 kg/m2; (4) the American Society of Anesthesiologists (ASA) classification (anesthesia risk assessment) is I ~ II level.

Exclusion criteria

Exclusion criteria: (1) allergic to anesthetic drugs and sulfa; (2) there were more than moderate intraoperative knee malformations (pronation and flexion malformations) and joint stiffness; (3) alcoholic or long-term opioid users; (4) language impairment and inability to perform pain numerical scales (NRS); (5) surgical limb neuropathy; (6) mental patients; (7) patients with previous sick sinus syndrome, severe sinus bradycardia(Heart rate < 50 beats/min) or severe atrioventricular block (type III).

Design outcomes

Primary

MeasureTime frame
Postoperative dosage of remedial morphine hydrochloride;Time of first postoperative analgesia;VAS pain score;QoR-15 score;Range of knee motion;Quadriceps strength;Daily walking distance;Incidence of postoperative complications;Time to first straight leg raise;The duration of hospital stay;inflammatory factor;AIS score;

Countries

China

Contacts

Public ContactZongke Zhou

West China Hospital, Sichuan University

zhouzongke@scu.edu.cn+86 18980601028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026